Total Payments
$2,412
2024 Payments
$84.69
Companies
20
Transactions
125
Medicare Patients
39,579
Medicare Billing
$4.0M
Payment Breakdown by Category
Food & Beverage$2,412 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,412 | 125 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $934.48 | 56 | $0 (2024) |
| Janssen Biotech, Inc. | $168.18 | 11 | $0 (2023) |
| Biofrontera Inc. | $156.31 | 2 | $0 (2023) |
| Incyte Corporation | $152.59 | 7 | $0 (2024) |
| Verrica Pharmaceuticals Inc. | $151.88 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $105.72 | 6 | $0 (2023) |
| Lilly USA, LLC | $104.48 | 7 | $0 (2021) |
| UCB, Inc. | $94.97 | 5 | $0 (2024) |
| PFIZER INC. | $93.26 | 5 | $0 (2023) |
| Galderma Laboratories, L.P. | $73.51 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.69 | 4 | ABBVIE INC. ($39.22) |
| 2023 | $554.69 | 10 | Verrica Pharmaceuticals Inc. ($151.88) |
| 2022 | $550.80 | 28 | ABBVIE INC. ($212.10) |
| 2021 | $195.85 | 12 | AbbVie Inc. ($75.80) |
| 2020 | $16.30 | 1 | Lilly USA, LLC ($16.30) |
| 2019 | $296.85 | 18 | AbbVie, Inc. ($95.04) |
| 2018 | $306.45 | 24 | AbbVie, Inc. ($144.78) |
| 2017 | $406.18 | 28 | AbbVie, Inc. ($225.42) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: IMMUNOLOGY | ||||||
| 06/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Immunology | ||||||
| 03/23/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.64 | General |
| Category: Dermatology | ||||||
| 01/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/14/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $122.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Immunology | ||||||
| 10/21/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $151.88 | General |
| Category: DERMATOLOGY | ||||||
| 10/20/2023 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $136.40 | General |
| Category: DERMATOLOGY | ||||||
| 03/08/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: IMMUNOLOGY | ||||||
| 02/15/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/07/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Immunology | ||||||
| 01/30/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, COMIRNATY | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: DERMATOLOGY | ||||||
| 01/25/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.31 | General |
| Category: Dermatology | ||||||
| 01/19/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.23 | General |
| Category: Dermatology | ||||||
| 11/30/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Immunology | ||||||
| 11/17/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Dermatology | ||||||
| 11/09/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Immunology | ||||||
| 11/02/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2022 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Dermatology | ||||||
| 10/26/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.03 | General |
| Category: Dermatology | ||||||
| 10/12/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO, PAXLOVID | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: DERMATOLOGY | ||||||
| 10/11/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/05/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Inflammation | ||||||
| 10/05/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Inflammation | ||||||
| 09/27/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 15,883 | 25,039 | $5.0M | $1.5M |
| 2022 | 33 | 8,588 | 14,878 | $2.9M | $883,787 |
| 2021 | 31 | 8,330 | 15,068 | $2.9M | $883,227 |
| 2020 | 28 | 6,778 | 11,438 | $2.1M | $657,802 |
Total Patients
39,579
Total Services
66,423
Medicare Billing
$4.0M
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 11,424 | 18,334 | $3.5M | $1.1M | 31.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 1,161 | 1,391 | $387,426 | $136,000 | 35.1% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 567 | 1,033 | $193,406 | $75,050 | 38.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 771 | 824 | $260,466 | $68,613 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 308 | 417 | $81,315 | $26,470 | 32.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 214 | $48,150 | $19,161 | 39.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 199 | 257 | $89,950 | $17,503 | 19.5% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 374 | 419 | $51,590 | $15,740 | 30.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 115 | 135 | $67,500 | $10,736 | 15.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 206 | 290 | $87,000 | $10,340 | 11.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 42 | 60 | $22,500 | $7,646 | 34.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 69 | 161 | $28,175 | $6,845 | 24.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 166 | 1,100 | $55,000 | $5,971 | 10.9% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 37 | 59 | $20,650 | $5,559 | 26.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 55 | 76 | $13,921 | $4,971 | 35.7% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 25 | 32 | $19,200 | $3,895 | 20.3% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 29 | 46 | $14,625 | $3,627 | 24.8% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 15 | 23 | $8,050 | $3,027 | 37.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 48 | 52 | $7,800 | $2,251 | 28.9% |
| 88365 | Genetic sequencing localization, initial procedure | Office | 2023 | 13 | 13 | $7,540 | $2,087 | 27.7% |
| 88364 | Genetic sequencing localization, each additional procedure | Office | 2023 | 12 | 12 | $5,400 | $1,449 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,575 | $1,437 | 40.2% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 14 | 14 | $4,900 | $1,276 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $4,750 | $1,180 | 24.8% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 11 | 11 | $3,575 | $1,007 | 28.2% |
About Dr. Debra Jih, M.D
Dr. Debra Jih, M.D is a Dermatopathology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790722981.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debra Jih, M.D has received a total of $2,412 in payments from pharmaceutical and medical device companies, with $84.69 received in 2024. These payments were reported across 125 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,412).
As a Medicare-enrolled provider, Jih has provided services to 39,579 Medicare beneficiaries, totaling 66,423 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Location Philadelphia, PA
- Active Since 05/31/2006
- Last Updated 07/21/2022
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1790722981
Products in Payments
- Humira (Biological) $345.58
- SKYRIZI (Biological) $264.13
- RINVOQ (Biological) $186.46
- AMELUZ (Drug) $156.31
- OPZELURA (Drug) $152.59
- YCANTH (Drug) $151.88
- TREMFYA (Drug) $116.81
- TALTZ (Drug) $104.48
- EUCRISA (Drug) $93.26
- DUPIXENT (Biological) $89.43
- Otezla (Drug) $67.69
- ADBRY (Biological) $65.19
- XTRAC (Device) $61.50
- Cimzia (Drug) $60.72
- EPIDUO FORTE (Drug) $39.67
- ILUMYA (Biological) $37.73
- Bimzelx (Biological) $34.25
- Tremfya (Drug) $33.94
- Enbrel (Biological) $28.00
- Skyrizi (Biological) $21.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in Philadelphia
John Seykora, Md, MD
Dermatopathology — Payments: $312,736
Dermatopathology $312,736
Jina Chung, M.d, M.D
Dermatopathology — Payments: $728.27
Dermatopathology $728.27
Dr. Herbert Allen, M.d, M.D
Dermatopathology — Payments: $285.43
Dermatopathology $285.43
Rosalie Elenitsas, Md, MD
Dermatopathology — Payments: $278.30
Dermatopathology $278.30
Faizan Alawi, Dds, DDS
Dermatopathology
Dermatopathology
Dr. Tai Wong, M.b.,Ch.b, M.B.,CH.B
Dermatopathology
Dermatopathology